Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2024-12-04 Regulatory Filings
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release announcing a significant corporate rebranding and strategic shift for the company, changing its name from Ikonisys SA to ALIKO SCIENTIFIC. It details the new vision, business structure (including subsidiaries like Hospitex), and future strategy pillars. This type of announcement, which focuses on corporate identity, strategy, and management direction rather than routine financial reporting (like 10-K, ER, or IR), best fits the 'Board/Management Information' category, as it outlines a major strategic direction often driven by management/board decisions. It is not a formal regulatory filing like a 10-K or a specific financial report like an ER or IR. Since it announces a change in corporate direction and branding, MANG (Board/Management Information) is the most appropriate fit among the provided options, as it signals a major strategic shift.
2024-12-04 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated December 4, 2024, announcing a major strategic shift: the rebranding of Ikonisys SA to 'ALIKO SCIENTIFIC' and outlining its new vision and strategy focused on oncology diagnostics. It discusses market size, strategic pillars (integration, expansion, technology watch), and provides contact information for investors and media. This type of announcement, detailing strategic direction, corporate structure changes (rebranding/acquisition integration), and future outlook, is characteristic of a general corporate update or investor relations communication, but it is not a formal regulatory filing like a 10-K, a specific financial report (IR, MRQ), or a transcript (CT). Since it is a formal announcement of corporate strategy and identity change, it fits best under the general category for corporate announcements that aren't strictly financial results or specific regulatory forms. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a significant, non-standard corporate press release, although 'Investor Presentation' (IP) or 'Management Reports' (MDA) could be considered if it were more detailed on performance. However, as a strategic rebranding press release, RNS serves as the best general fit among the provided codes for a non-standard announcement.
2024-12-04 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated November 25, 2024, announcing a significant commercial achievement: securing a major public contract for the Ikoniscope20 robotic microscope in Italy. It details the value (€123k), the context (public tender win), and positions this event within the company's broader commercial strategy, referencing recent agreements and future outlook. This type of announcement, focusing on a specific business development, contract win, or strategic milestone, is characteristic of an Earnings Release (ER) if it were summarizing period results, but since it is a specific, non-periodic business update, it fits best under the general category of a significant corporate announcement. Given the options, it is not a formal regulatory filing (like 10-K or IR), nor is it a transcript, management discussion, or proxy material. It is a news announcement about business operations and contracts. Since there is no specific code for 'Business Update' or 'Contract Announcement', and it is not a formal financial report, the most appropriate general category for a significant, non-periodic corporate announcement that doesn't fit other specific financial/regulatory codes is the Regulatory Filings fallback (RNS), or potentially an Earnings Release (ER) if it were part of a quarterly cycle, but here it is a standalone event announcement. However, looking closely at the definitions, this is a direct announcement of a business event, not a formal regulatory filing (RNS) or a summary of financial results (ER). It is a press release detailing a commercial success. In many databases, such announcements fall under 'Regulatory Filings' (RNS) if they are required disclosures, or sometimes they are classified as 'Investor Relations' material. Given the provided list, and since it is a direct announcement of a commercial event rather than a formal report, RNS (Regulatory Filings/General Announcement) is the most suitable fallback, although it strongly resembles an Earnings Release structure (headline, quote, boilerplate) but lacks the actual financial figures for a period. Since it is a specific, material business event announcement, RNS is the best fit among the provided codes for non-standard disclosures.
2024-11-25 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated November 25, 2024, announcing that Ikonisys SA, through its subsidiary Hospitex, won a major public contract in Italy for its Ikoniscope20 robotic microscope. This announcement details a significant commercial achievement, a contract value (€123 K€), and quotes the Chief Operating Officer. This type of announcement, focusing on a specific business development, contract win, or operational milestone, is typically classified as a general business update or regulatory filing. Since it is not a formal financial report (10-K, IR, ER, MRQ), a management discussion (MDA), a capital event (CAP, SHA), or a specific shareholder action (DIV, DVA), it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for significant, non-standard corporate news releases that are often filed with regulators.
2024-11-25 French
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a press release titled "Ikonisys a finalisé une augmentation de capital par le biais d'un placement privé" (Ikonisys finalized a capital increase through a private placement). It details the issuance of new ordinary shares, the amount raised (200 K€), the price per share, and the resulting dilution and capital structure changes. This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report (RPA/RNS), as it contains the substantive details of the transaction itself.
2024-11-19 French
Inside Information / Other news releases
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated November 19, 2024, announcing that Ikonisys SA has completed a capital increase of €200k through a private placement. It details the legal terms, the number of shares issued (130,720), the issuance price, and the impact on shareholder capital structure. This content directly relates to fundraising, financing activities, and changes in capital structure. This aligns perfectly with the definition of 'Capital/Financing Update' (Code: CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV).
2024-11-19 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.